FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Roxane Laboratories Azelastine Hydrochloride Nasal Solution Recall

Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0

Roxane Laboratories, Inc. · Columbus, OH

Risk level
Class III
Reported by FDA
Feb 1, 2017
Recall ID
D-0448-2017
Check your lot numberHow we source this data

Summary

Roxane Laboratories recalled Azelastine Hydrochloride Nasal Solution starting Dec 14, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0448-2017 on Feb 1, 2017. Reason: Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point.. Status: Terminated.

Why it was recalled

Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..

Product description

Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0.1% (137 mcg per spray), packaged in 30 mL bottles, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-0293-99

Lot numbers, UPCs & expiration codes

Lot # 659365A, Exp 3/31/2018

Where it was sold

Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0448-2017
Classification
Class III
Status
Terminated
Recall initiated
Dec 14, 2016
FDA report date
Feb 1, 2017
Quantity
74,108 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Roxane Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0448-2017, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
75992
Address
1809 Wilson Rd
Code information
Lot # 659365A, Exp 3/31/2018
Postal code
43228-9579
Report date
Feb 1, 2017
Product type
Drugs
Recall number
D-0448-2017
Classification
Class III
Recalling firm
Roxane Laboratories, Inc.
Product quantity
74,108 bottles
Termination date
Dec 15, 2017
Reason for recall
Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..
Voluntary / mandated
Voluntary: Firm initiated
Product description
Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0.1% (137 mcg per spray), packaged in 30 mL bottles, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-0293-99
Distribution pattern
Nationwide and Puerto Rico.
Recall initiation date
Dec 14, 2016
Initial firm notification
Letter
Center classification date
Jan 26, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0448-2017, published Feb 1, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls